| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | 0.22 | 0.2 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.2 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.39 | 0.2 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.2 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.2 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.21 | 0.2 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |